| P50 | author | H. Burkhard Dick | Q108312652 |
| P2093 | author name string | Marc Schargus | |
| | Sara C Gomes | |
| | Sabrina Reinehr | |
| | Stephanie C Joachim | |
| | Gesa Stute | |
| | Caroline J Gassel | |
| | M Ali Asaad | |
| P2860 | cites work | The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 |
| | Spectral-domain optical coherence tomography of the rodent eye: highlighting layers of the outer retina using signal averaging and comparison with histology | Q27334561 |
| | Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD | Q28140882 |
| | The a-wave of the dark adapted electroretinogram in glaucomas: are photoreceptors affected? | Q28361097 |
| | Oxidative stress and the regulation of complement activation in human glaucoma | Q28577665 |
| | C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis | Q28578796 |
| | Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR | Q29400573 |
| | Swelling and loss of photoreceptors in chronic human and experimental glaucomas | Q30839393 |
| | Changes in the inner and outer retinal layers after acute increase of the intraocular pressure in adult albino Swiss mice | Q30986373 |
| | Retinal synthesis and deposition of complement components induced by ocular hypertension. | Q33242506 |
| | Altered nitric oxide system in patients with open-angle glaucoma | Q33281593 |
| | IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma | Q33300223 |
| | Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens | Q33314556 |
| | Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma | Q33917505 |
| | Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma | Q33984464 |
| | Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma | Q34755301 |
| | Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma | Q35056596 |
| | Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid | Q35068037 |
| | The pathophysiology and treatment of glaucoma: a review | Q35168230 |
| | Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors. | Q35541085 |
| | The immune system and glaucoma | Q35691309 |
| | In Vivo Imaging of Fluorescent Probes Linked to Antibodies Against Human and Rat Vascular Endothelial Growth Factor | Q35939928 |
| | Optic Nerve Head Blood Flow, as Measured by Laser Speckle Flowgraphy, Is Significantly Reduced in Preperimetric Glaucoma | Q36012155 |
| | Autoimmunity and glaucoma | Q37095751 |
| | Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand | Q37195253 |
| | The role of glia, mitochondria, and the immune system in glaucoma | Q37401610 |
| | The case for autoimmunity in glaucoma | Q37783777 |
| | Does autoimmunity play a part in the pathogenesis of glaucoma? | Q38094462 |
| | Retinal ganglion cells: Energetics, compartmentation, axonal transport, cytoskeletons and vulnerability | Q38124635 |
| | Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27. | Q38759153 |
| | Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis | Q38904200 |
| | Evaluating retinal ganglion cell loss and dysfunction | Q38927439 |
| | Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination | Q39260087 |
| | Immune response against ocular tissues after immunization with optic nerve antigens in a model of autoimmune glaucoma | Q39366776 |
| | Complex autoantibody repertoires in patients with glaucoma | Q39677385 |
| | Therapeutic Inhibition of Complement: Well Worth the Risk | Q40249453 |
| | Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain | Q40306336 |
| | Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States | Q40347336 |
| | Physiology and pathophysiology of complement: progress and trends. | Q40380370 |
| | Protective effects on the retina after ranibizumab treatment in an ischemia model | Q41363983 |
| | Early remodelling of the extracellular matrix proteins tenascin-C and phosphacan in retina and optic nerve of an experimental autoimmune glaucoma model | Q41592935 |
| | Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT. | Q41966541 |
| | Intravitreal Injection of Bone Marrow Mesenchymal Stem Cells in Patients with Advanced Retinitis Pigmentosa; a Safety Study | Q42317934 |
| | The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma | Q42748164 |
| | Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model. | Q42748914 |
| | Loss of retinal function in aged DBA/2J mice - New insights into retinal neurodegeneration | Q42910603 |
| | Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. | Q43096209 |
| | Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. | Q43225419 |
| | Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. | Q44241464 |
| | Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. | Q45926332 |
| | Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension | Q46694030 |
| | HSP27 immunization reinforces AII amacrine cell and synapse damage induced by S100 in an autoimmune glaucoma model | Q47611400 |
| | Rat retinal microglial cells under normal conditions, after optic nerve section, and after optic nerve section and intravitreal injection of trophic factors or macrophage inhibitory factor | Q48268120 |
| | Systemic circulatory parameters. comparison between patients with normal tension glaucoma and normal subjects using ambulatory monitoring | Q48686172 |
| | Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens | Q48834661 |
| | Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema | Q50097258 |
| | Concentration-Dependent Inner Retina Layer Damage and Optic Nerve Degeneration in a NMDA Model | Q50151785 |
| | Different Ipsi- and Contralateral Glial Responses to Anti-VEGF and Triamcinolone Intravitreal Injections in Rats. | Q51662674 |
| | Systemic ocular antigen immunization leads only to a minor secondary immune response. | Q53128844 |
| | S100 alone has the same destructive effect on retinal ganglion cells as in combination with HSP 27 in an autoimmune glaucoma model. | Q53647549 |
| | Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. | Q53926835 |
| | Autoantibodies to small heat shock proteins in glaucoma. | Q53943140 |
| | Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 by microglia/macrophages is associated with focal photoreceptor degeneration. | Q54373091 |
| | S100B immunization triggers NFκB and complement activation in an autoimmune glaucoma model. | Q55507765 |
| | Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia Model. | Q55692320 |
| | The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis | Q77852567 |
| | Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice | Q79360264 |
| | Primary open-angle glaucoma | Q80122027 |
| | Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor | Q80572007 |
| | Mitochondrial abnormalities in patients with primary open-angle glaucoma | Q83839662 |
| | Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model | Q87041812 |
| | [Diurnal Fluctuations of Intraocular Pressure, Blood Pressure, and Ocular Perfusion Pressure in Glaucoma Patients] | Q87077947 |
| | Loss of inner retinal neurons after retinal ischemia in rats | Q87609013 |
| | European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 2: Classification and terminologySupported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology | Q87867736 |
| | [Complement activation after induction of ocular hypertension in an animal model] | Q88104982 |
| | Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma | Q92391828 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | retinal degeneration | Q3043268 |
| P304 | page(s) | 1381 | |
| P577 | publication date | 2019-12-02 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model | |
| P478 | volume | 10 | |